BridgeMD
New treatment option for Cell Carcinoma
Official title Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma
ClinicalTrials.gov ID: NCT06112522
What this study is testing
What is Tirbanibulin?
Tirbanibulin is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for cell carcinoma.
Also referred to as Tirbaso.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- his is a Phase 2, Single-Arm, Open-Label, Single Center, to Assess Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects with superficial basal cell carcinoma (sBCC) not arising on the face or scalp
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \> 18 years
- Histologically confirmed,
- primary, previously untreated,
- superficial basal cell carcinoma (sBCC) not arising on the face or scalp, ≤ 15 mm (large axis)
You likely can't join if
- BCC of the face or scalp
- BCC of non-superficial subtype
- BCC with large axis \> 15mm
- Relapsing BCC
- Allergy to treatment
- Treatment with cryotherapy, imiquimod, PDT, or radiotherapy in the BCC area during the 6 months prior to the screening visit
The study team makes the final eligibility decision.
Where it's taking place
- Nice, Alpes-maritimes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nice, Alpes-maritimes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.